196 related articles for article (PubMed ID: 23076626)
1. Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart.
Buccini S; Haider KH; Ahmed RP; Jiang S; Ashraf M
Basic Res Cardiol; 2012 Nov; 107(6):301. PubMed ID: 23076626
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart.
Ahmed RP; Haider HK; Buccini S; Li L; Jiang S; Ashraf M
Circ Res; 2011 Jun; 109(1):60-70. PubMed ID: 21566212
[TBL] [Abstract][Full Text] [Related]
3. Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.
Wang H; Xi Y; Zheng Y; Wang X; Cooney AJ
Stem Cell Res; 2016 Mar; 16(2):522-30. PubMed ID: 26972055
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium.
Singla DK; Long X; Glass C; Singla RD; Yan B
Mol Pharm; 2011 Oct; 8(5):1573-81. PubMed ID: 21542647
[TBL] [Abstract][Full Text] [Related]
5. Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells.
Pasha Z; Haider HKh; Ashraf M
PLoS One; 2011; 6(8):e23667. PubMed ID: 21886809
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.
Noiseux N; Gnecchi M; Lopez-Ilasaca M; Zhang L; Solomon SD; Deb A; Dzau VJ; Pratt RE
Mol Ther; 2006 Dec; 14(6):840-50. PubMed ID: 16965940
[TBL] [Abstract][Full Text] [Related]
7. Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells.
Ge X; Wang IN; Toma I; Sebastiano V; Liu J; Butte MJ; Reijo Pera RA; Yang PC
Stem Cells Dev; 2012 Oct; 21(15):2798-808. PubMed ID: 22530853
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes.
Jiang B; Dong H; Li Q; Yu Y; Zhang Z; Zhang Y; Wang G; Zhang Z
Cell Biochem Biophys; 2013 Jun; 66(2):309-18. PubMed ID: 23212180
[TBL] [Abstract][Full Text] [Related]
9. Direct differentiation of rat skin fibroblasts into cardiomyocytes.
Ahmad W; Saleh B; Qazi RE; Muneer R; Khan I; Khan M; Salim A
Exp Cell Res; 2024 Feb; 435(2):113934. PubMed ID: 38237847
[TBL] [Abstract][Full Text] [Related]
10. Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance.
van Laake LW; Qian L; Cheng P; Huang Y; Hsiao EC; Conklin BR; Srivastava D
Circ Res; 2010 Aug; 107(3):340-7. PubMed ID: 20558827
[TBL] [Abstract][Full Text] [Related]
11. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
12. The harsh microenvironment in infarcted heart accelerates transplanted bone marrow mesenchymal stem cells injury: the role of injured cardiomyocytes-derived exosomes.
Hu M; Guo G; Huang Q; Cheng C; Xu R; Li A; Liu N; Liu S
Cell Death Dis; 2018 Mar; 9(3):357. PubMed ID: 29500342
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.
Siegel G; Krause P; Wöhrle S; Nowak P; Ayturan M; Kluba T; Brehm BR; Neumeister B; Köhler D; Rosenberger P; Just L; Northoff H; Schäfer R
Stem Cells Dev; 2012 Sep; 21(13):2457-70. PubMed ID: 22309203
[TBL] [Abstract][Full Text] [Related]
14. Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice.
Yan B; Abdelli LS; Singla DK
Mol Pharm; 2011 Oct; 8(5):1602-10. PubMed ID: 21851072
[TBL] [Abstract][Full Text] [Related]
15. Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function.
Kim HW; Jiang S; Ashraf M; Haider KH
J Mol Med (Berl); 2012 Sep; 90(9):997-1010. PubMed ID: 22648522
[TBL] [Abstract][Full Text] [Related]
16. Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction.
Yannarelli G; Tsoporis JN; Desjardins JF; Wang XH; Pourdjabbar A; Viswanathan S; Parker TG; Keating A
Stem Cell Rev Rep; 2014 Apr; 10(2):304-15. PubMed ID: 24287730
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
Velasquez-Mao AJ; Tsao CJM; Monroe MN; Legras X; Bissig-Choisat B; Bissig KD; Ruano R; Jacot JG
PLoS One; 2017; 12(5):e0177824. PubMed ID: 28545044
[TBL] [Abstract][Full Text] [Related]
18. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
[TBL] [Abstract][Full Text] [Related]
20. Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction.
Ahmed RP; Ashraf M; Buccini S; Shujia J; Haider HKh
Regen Med; 2011 Mar; 6(2):171-8. PubMed ID: 21391851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
